The Ledger

Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.

clear all ✕

why aren't all 3 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable

Insight
Narasimhan: AAV vectors enable reusable platform delivery in gene therapy
“When you think about AAV vectors, these are ways to deliver these gene therapies into the body. Once you solve it, the process, let's say for one of these vectors, you can apply it to multiple different diseases and not have to Recreate everything again. That'…”
Vas Narasimhan Jan 17, 2019 ▶ 31:13 a16z Podcast | The Science and Business of Innovative Medicines
Insight
Rebuilding an abandoned pharmaceutical R&D division takes 10 years
“Because you can't change your mind now, you know, in three or four years and say, I wish I had it back. It'll take you another 10 years to build it back up again.”
Vas Narasimhan Jan 17, 2019 ▶ 3:48 a16z Podcast | The Science and Business of Innovative Medicines
Insight
Narasimhan: Novartis R&D pipeline is a zero-sum game
“Because if you take another program on, that means that there's another program you have to stop. I mean, it's a zero sum game for us.”
Vas Narasimhan Jan 17, 2019 ▶ 53:17 a16z Podcast | The Science and Business of Innovative Medicines
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.